Malhotra et al (p. 1438) retrospectively analyzed 203 673 patients from the Intelligent Research in Sight Registry® database to understand risk factors—including race, ethnicity, and insurance status—for poor baseline visual acuity (VA) diabetic retinopathy (DR) severity upon initiation of anti-VEGF therapy for macular edema (DME). Ethnicity, status were independently associated with worse VA D...